Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypothalamic-Pituitary Axis

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.

An Overview of Psychoactive Drugs

An Overview of Psychoactive Drugs

Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology.

Journal of endocrinological investigation·2025

Same author

Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT).

European journal of endocrinology·2025

Same author

Correction: Unusual infections and thrombotic events in Cushing's syndrome.

Journal of endocrinological investigation·2024

Same author

Unusual infections and thrombotic events in Cushing's syndrome.

Journal of endocrinological investigation·2024

Same author

A novel somatostatin receptor ligand for human ACTH - and GH -secreting pituitary adenomas.

European journal of endocrinology·2023

Same author

Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.

Neuroendocrinology·2023

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Drugs and HPA axis.

Alberto Giacinto Ambrogio¹, Francesca Pecori Giraldi, Francesco Cavagnini

¹Istituto Auxologico Italiano, Ospedale San Luca, IRCCS, University of Milan, Milan, Italy.

|April 12, 2008

Summary

This summary is machine-generated.

Many common medications interfere with hypothalamo-pituitary-adrenal (HPA) function and lab tests. This guide helps clinicians interpret results during testing for cortisol imbalances.

More Related Videos

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

Restraint to Induce Stress in Mice and Rats

Restraint to Induce Stress in Mice and Rats

Published on: December 6, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

Restraint to Induce Stress in Mice and Rats

Restraint to Induce Stress in Mice and Rats

Published on: December 6, 2024

Area of Science:

Endocrinology
Clinical Pharmacology

Background:

The hypothalamo-pituitary-adrenal (HPA) axis regulates cortisol production.
Drug-induced alterations in HPA function can mimic or mask endocrine disorders.
Accurate diagnosis of cortisol imbalances requires understanding potential drug interferences.

Purpose of the Study:

To review common medications affecting HPA axis function.
To detail the impact of these drugs on relevant laboratory parameters.
To provide practical guidance for clinicians managing patients with suspected cortisol abnormalities.

Main Methods:

Literature review of widely used drugs and their effects on HPA axis.
Analysis of drug-induced changes in cortisol and related biomarker assays.
Synthesis of information for clinical application.

Main Results:

Identified key drug classes interfering with HPA axis.
Described specific mechanisms of interference (e.g., receptor binding, enzyme inhibition).
Highlighted common laboratory test abnormalities caused by these drugs.

Conclusions:

Clinicians must consider drug history when evaluating HPA axis function.
Awareness of drug interferences is crucial for accurate diagnosis of hypo- or hypercortisolemia.
This review serves as a resource for optimizing diagnostic testing in patients on medication.